Found: 3
Select item for more details and to access through your institution.
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 103, doi. 10.1007/s10637-017-0530-4
- By:
- Publication type:
- Article
Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 5, p. 727, doi. 10.1007/s00280-012-1959-y
- By:
- Publication type:
- Article
FCGR2A and FCGR3A Genotypes Correlate with Farletuzumab Response in Patients with First-Relapsed Ovarian Cancer Exhibiting Low CA125.
- Published in:
- Cytogenetic & Genome Research, 2017, v. 152, n. 4, p. 169, doi. 10.1159/000481213
- By:
- Publication type:
- Article